(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) rose 5.05% to $5.82 at 10:17 EST on Wednesday, following the last session’s downward trend. NASDAQ Composite is jumping 1.25% to $14,433.83, after two successive sessions in a row of losses. This seems, at the moment, an all-around bullish trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $5.21, 16.51% below its 52-week high of $6.24.


Today’s last reported volume for Catalyst Pharmaceuticals is 278770 which is 66.37% below its average volume of 829160.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the current quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 0.39%, a negative 0.28%, and a positive 1.72%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.34% (last week), 1.51% (last month), and 1.72% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be overbought (>=80).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.82 at 10:17 EST, under its 52-week high of $6.24 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is way higher than its 50-day moving average of $5.26 and way above its 200-day moving average of $5.26.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here